Filter clotting with continuous renal replacement therapy in COVID-19
Paul Endres(Massachusetts General Hospital), Andrew S. Allegretti(Massachusetts General Hospital), David Steele(Harvard University), Russel J. Roberts(Massachusetts General Hospital), Eugene P. Rhee(Mass General Brigham), Finnian R. Mc Causland(Brigham and Women's Hospital), Peter G. Czarnecki(Beth Israel Deaconess Medical Center), Andrew L. Lundquist(Harvard University), Meghan E. Sise(Harvard University), Kathryn A. Hibbert(Duke University), Shananssa Percy(Massachusetts General Hospital), C. Corey Hardin(Massachusetts General Hospital), Rachel Rosovsky(Harvard University), Natasha Lopez(Massachusetts General Hospital), Nina Tolkoff-Rubin(Harvard University), Omer Kamal(Brigham and Women's Hospital), Scott Krinsky(Massachusetts General Hospital), Walter P. Mutter(Newton Wellesley Hospital), Sophia Zhao(Austin Health)
Cited by 27
Related Papers
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
|New England Journal of Medicine|2008|972
Vitamin D levels and early mortality among incident hemodialysis patients
|Kidney International|2007|791
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2014|524
Acute Humoral Rejection in Kidney Transplantation
|Journal of the American Society of Nephrology|2002|491
Chronic Humoral Rejection
|Journal of the American Society of Nephrology|2001|471